9月15日，甲骨文盘前短线拉升，现涨超4%。
高盛在最新报告大幅上调甲骨文目标价但维持“中性”评级，其认为巨额资本支出将推迟至现金流盈亏平衡至29财年，而且能否转化为营收增长仍缺乏明确的可见性。
高盛在甲骨文26财年第二季度业绩发布后，将其目标价从195美元大幅上调至310美元，甲骨文目前股价为292.18美元，目前约有6%上涨空间，同时高盛维持中性评级不变。
9月15日，甲骨文盘前短线拉升，现涨超4%。
高盛在最新报告大幅上调甲骨文目标价但维持“中性”评级，其认为巨额资本支出将推迟至现金流盈亏平衡至29财年，而且能否转化为营收增长仍缺乏明确的可见性。
高盛在甲骨文26财年第二季度业绩发布后，将其目标价从195美元大幅上调至310美元，甲骨文目前股价为292.18美元，目前约有6%上涨空间，同时高盛维持中性评级不变。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.